Veterans Health System Beats Medicare in Colon Cancer Survival

Older men with several kinds of cancer–including colon cancer–do as well or better in the Veterans’ Health Administration as men covered by Medicare, according to a new study published by the Journal of Clinical Oncology in an advanced online release. The Veterans’ Administration is the…

Read Full Post

Early Palliative Care Increases Survival Time

Should cancer care focused on quality of life wait until all treatment ends?  Or can it be integrated with medical treatment as soon as someone is diagnosed with a life-threatening illness? In a study of 150 advanced lung cancer patients, starting palliative care along with…

Read Full Post

Colorectal Cancer Research Briefs: Patients want colonoscopy videos

Briefly Hormone replacement therapy reduces risk of colon cancer. Smoking before age 30 increases chances that colon cancer will recur. Low CEA levels improve both survival and disease-free survival for stage II colon cancer. Most patients want videos of their colonoscopies and are willing to…

Read Full Post

Patient Outcomes Vary Depending on Liver Resectability

Patients with stage IV colorectal cancer live longer when tumors in their liver can be removed surgically, but not all patients have cancer that can be operated on. Separating patients with liver tumors from colorectal cancer into three groups according to possible liver resectability, British…

Read Full Post

Which Side of the Colon Matters

More evidence is emerging that right-sided colon cancers are different in significant ways from those on the left side. Information from 17,641 colon cancer patients in the German Colon/Rectum Cancer Study Group found that people with cancers on the right side of the colon were…

Read Full Post

Value of KRAS and BRAF Mutations in Forecasting Survival

For stage II and III colon cancer, a tumor mutation in the KRAS gene does not impact either relapse-free survival or overall survival. BRAF mutations, which are less common, don’t help with prognosis for relapse-free survival, but do provide information about overall survival in some…

Read Full Post

NSAIDS Reduce Deaths from Colorectal Cancer

Using non-steroidal anti-inflammatory medicines (NSAIDS) before being diagnosed with colorectal cancer reduced women’s deaths both from any cause and from colorectal cancer five years later. Women followed as part of the California Teachers Study who used NSAIDS regularly had more than 40 percent reduction in…

Read Full Post

Biomarkers Predict Colorectal Cancer Survival

Two gene changes that occur in some colorectal cancers can forecast chances for good or poor survival. Patients whose cancers had high microsatellite instability (MSI) had significantly better outcomes at every stage, but mutations in the KRAS gene predicted poorer survival.

Read Full Post

Early Stage Patients Benefit from Regular Follow-Up

Patients with very early stage colon cancer benefit as much from regular followup testing after surgery as later stage patients do. While overall patients with stage I or IIA colon cancer (early stage) have a lower risk of cancer returning than patients with stage IIB or…

Read Full Post
Page 1 of 3123